379 related articles for article (PubMed ID: 28465792)
1. Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study.
Arnason TG; Bowen MW; Mansell KD
World J Diabetes; 2017 Apr; 8(4):154-164. PubMed ID: 28465792
[TBL] [Abstract][Full Text] [Related]
2. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
3. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
5. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
DeFronzo RA; Buse JB; Kim T; Burns C; Skare S; Baron A; Fineman M
Diabetologia; 2016 Aug; 59(8):1645-54. PubMed ID: 27216492
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
[TBL] [Abstract][Full Text] [Related]
7. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
8. Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with type 2 diabetes: a randomized crossover trial.
Carrillo BJP; Cope E; Gurel S; Traslosheros A; Kenny A; Michot-Duval O; Mody N; Delibegovic M; Philip S; Thies F; Blana D; Gabriel BM
J Physiol; 2024 Mar; ():. PubMed ID: 38522033
[TBL] [Abstract][Full Text] [Related]
9. EADSG Guidelines: Insulin Therapy in Diabetes.
Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
[TBL] [Abstract][Full Text] [Related]
10. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
11. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon.
Troisi RJ; Cowie CC; Harris MI
JAMA; 2000 Dec; 284(24):3157-9. PubMed ID: 11135780
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance.
Stange R; Pflugbeil C; Michalsen A; Uehleke B
Forsch Komplementmed; 2013; 20(6):421-6. PubMed ID: 24434756
[TBL] [Abstract][Full Text] [Related]
13. A meal replacement regimen improves blood glucose levels in prediabetic healthy individuals with impaired fasting glucose.
König D; Kookhan S; Schaffner D; Deibert P; Berg A
Nutrition; 2014; 30(11-12):1306-9. PubMed ID: 25194963
[TBL] [Abstract][Full Text] [Related]
14. The effect of different times of day for exercise on blood glucose fluctuations.
Niu WC; Liu C; Liu K; Fang WJ; Liu XQ; Liang XL; Yuan HP; Jia HM; Peng HF; Jiang HW; Jia ZM
Prim Care Diabetes; 2024 Jun; ():. PubMed ID: 38897914
[TBL] [Abstract][Full Text] [Related]
15. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
[TBL] [Abstract][Full Text] [Related]
16. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.
Briatore L; Salani B; Andraghetti G; Danovaro C; Sferrazzo E; Scopinaro N; Adami GF; Maggi D; Cordera R
Obesity (Silver Spring); 2008 Jan; 16(1):77-81. PubMed ID: 18223616
[TBL] [Abstract][Full Text] [Related]
17. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
18. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
